$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

$nwbo Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000114420415047830 Filed on August 10, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$391.0K	$0.00
YoY Change		-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$9.810M	$3.880M
YoY Change	152.84%	17.93%
% of Gross Profit
Research & Development	$27.80M	$21.55M
YoY Change	29.0%	157.06%
% of Gross Profit
Depreciation & Amortization	$12.00K	$10.00K
YoY Change	20.0%	0.0%
% of Gross Profit
Operating Expenses	$27.80M	$21.55M
YoY Change	29.0%	157.06%
Operating Profit	-$38.85M	-$25.43M
YoY Change	52.81%	122.97%
Interest Expense	$1.636M	$33.00K
YoY Change	4857.58%	-82.63%
% of Operating Profit
Other Income/Expense, Net	-$27.99M	-$438.0K
YoY Change	6290.64%
Pretax Income	-$66.85M	-$25.87M
YoY Change	158.41%	123.21%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$66.85M	-$25.87M
YoY Change	158.44%	123.09%
Net Earnings / Revenue	-17095.91%
Basic Earnings Per Share	-$0.88
Diluted Earnings Per Share	-$0.88	-$450.4K
COMMON SHARES
Basic Shares Outstanding	76.89M shares	57.20M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.20M	$8.850M
YoY Change	116.95%	344.72%
Cash & Equivalents	$19.20M	$8.853M
Short-Term Investments
Other Short-Term Assets	$2.000M	$3.590M
YoY Change	-44.29%	897.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$21.20M	$12.44M
YoY Change	70.37%	429.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$42.00M	$77.00K
YoY Change	54444.16%	-13.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.050M	$55.00K
YoY Change	1809.09%
Total Long-Term Assets	$43.05M	$132.0K
YoY Change	32511.36%	48.31%
TOTAL ASSETS
Total Short-Term Assets	$21.20M	$12.44M
Total Long-Term Assets	$43.05M	$132.0K
Total Assets	$64.25M	$12.58M
YoY Change	410.89%	416.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.07M	$9.543M
YoY Change	16.02%	-37.66%
Accrued Expenses	$1.188M	$655.0K
YoY Change	81.37%	-39.8%
Deferred Revenue
YoY Change
Short-Term Debt	$930.0K	$930.0K
YoY Change	0.0%	0.0%
Long-Term Debt Due	$240.0K	$240.0K
YoY Change	0.0%	-82.09%
Total Short-Term Liabilities	$116.5M	$42.45M
YoY Change	174.56%	127.31%
LONG-TERM LIABILITIES
Long-Term Debt	$23.72M	$0.00
YoY Change
Other Long-Term Liabilities	$149.0K
YoY Change
Total Long-Term Liabilities	$23.87M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$116.5M	$42.45M
Total Long-Term Liabilities	$23.87M	$0.00
Total Liabilities	$140.4M	$42.45M
YoY Change	230.79%	127.32%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$557.2M	$427.2M
YoY Change	30.42%	34.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$76.17M	-$29.87M
YoY Change
Total Liabilities & Shareholders Equity	$64.25M	$12.58M
YoY Change	410.88%	416.04%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	-$66.85M	-$25.87M
YoY Change	158.44%	123.09%
Depreciation, Depletion And Amortization	$12.00K	$10.00K
YoY Change	20.0%	0.0%
Cash From Operating Activities	-$27.10M	-$16.94M
YoY Change	59.98%	106.33%
INVESTING ACTIVITIES
Capital Expenditures	-$890.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$3.410M
YoY Change	-100.0%
Cash From Investing Activities	-$890.0K	-$3.410M
YoY Change	-73.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	43.20M	16.98M
YoY Change	154.42%	72.91%
NET CHANGE
Cash From Operating Activities	-27.10M	-16.94M
Cash From Investing Activities	-890.0K	-3.410M
Cash From Financing Activities	43.20M	16.98M
Net Change In Cash	15.21M	-3.370M
YoY Change	-551.34%	-309.32%
FREE CASH FLOW
Cash From Operating Activities	-$27.10M	-$16.94M
Capital Expenditures	-$890.0K
Free Cash Flow	-$26.21M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	nwbo	Development Stage Enterprise Deficit Accumulated During Development Stage1 DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage1	520521000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56456000	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22603000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	91483000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	-76171000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64248000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	485615000	USD
CY2015Q2	nwbo	Development Stage Enterprise Deficit Accumulated During Development Stage1 DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage1	633799000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-35027000	USD
CY2014Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	238000	USD
CY2014Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	41814000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	14642000	USD
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	557136000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	414000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-190000	USD
CY2014Q2	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
CY2015Q2	us-gaap	Revenue From Grants RevenueFromGrants	391000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-38854000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	57442000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	75619000	shares
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	USD
	us-gaap	Revenue From Grants RevenueFromGrants	585000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	585000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41535000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49137000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7576000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13133000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	49111000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	62270000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1188000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1211000	USD
CY2015Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	238000	USD
CY2015Q2	us-gaap	Notes Payable Current NotesPayableCurrent	934000	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	934000	USD
CY2015Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	92716000	USD
CY2014Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	44742000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	116546000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	68880000	USD
CY2015Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	12323000	USD
CY2014Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	16377000	USD
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	23873000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	55000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39999000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41999000	USD
CY2015Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	43047000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-66845000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-25865000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-48852000	USD
CY2015Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-661000	USD
	us-gaap	Interest Expense InterestExpense	155000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-61685000	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	69000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	78000	USD
CY2015Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	11401000	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	6128000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	140419000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	0	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9826000	USD
CY2015Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	4198000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	21201000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	387000	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	978000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13390000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19202000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	149000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	98000	USD
CY2015Q2	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1021000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	391000	USD
CY2014Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	865000	USD
CY2015Q2	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	739000	USD
CY2014Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	1760000	USD
CY2015Q2	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	6200000	USD
CY2014Q4	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	6200000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21549000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	11072000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9811000	USD
CY2014Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	5729000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-25427000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29434000	USD
CY2014Q2	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	5089000	USD
CY2014Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	25427000	USD
CY2015Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	39245000	USD
CY2015Q2	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
CY2014Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4684000	USD
CY2015Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-25694000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	33000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	1636000	USD
	nwbo	Redeemable Security Settlement RedeemableSecuritySettlement	0	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3878000	USD
	us-gaap	Site Contingency Loss Exposure In Excess Of Accrual High Estimate SiteContingencyLossExposureInExcessOfAccrualHighEstimate	4500000	USD
	us-gaap	Site Contingency Loss Exposure In Excess Of Accrual Low Estimate SiteContingencyLossExposureInExcessOfAccrualLowEstimate	32000000	USD
	us-gaap	Site Contingency Loss Exposure In Excess Of Accrual Best Estimate SiteContingencyLossExposureInExcessOfAccrualBestEstimate	6200000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	30000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-49111000	USD
	nwbo	Cash Payments For Services CashPaymentsForServices	4200000	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-12300000	USD
	us-gaap	Interest Expense InterestExpense	2429000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-71906000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-113278000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.31
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.56
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	54923000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	72530000	shares
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-312000	USD
	nwbo	Stock Issued During Period Value Issued For Non Cash Consideration StockIssuedDuringPeriodValueIssuedForNonCashConsideration	521000	USD
	nwbo	Stock Issued During Period Value Redeemable Securities Settlement StockIssuedDuringPeriodValueRedeemableSecuritiesSettlement	299000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	591000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1385000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	2211000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	7986000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-1529000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27498000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44684000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2015000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3414000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2015000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	25000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	nwbo	Accrued Interest Converted To Common Stock AccruedInterestConvertedToCommonStock	0	USD
	nwbo	Stock And Warrants Issued To Related Party Expenses StockAndWarrantsIssuedToRelatedPartyExpenses	10623000	USD
	nwbo	Stock And Warrants Issued To Related Party Expenses StockAndWarrantsIssuedToRelatedPartyExpenses	15784000	USD
	nwbo	Stock And Warrants Issued For Services And Other Expenses StockAndWarrantsIssuedForServicesAndOtherExpenses	1722000	USD
	nwbo	Stock And Warrants Issued For Services And Other Expenses StockAndWarrantsIssuedForServicesAndOtherExpenses	3389000	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	10340000	USD
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	0	USD
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	4997000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	138000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18499000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8853000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	717000	USD
	nwbo	Accrued Interest Converted To Common Stock AccruedInterestConvertedToCommonStock	76000	USD
	nwbo	Reclass Of Redeemable Security To Equity ReclassOfRedeemableSecurityToEquity	8913000	USD
	nwbo	Reclass Of Redeemable Security To Equity ReclassOfRedeemableSecurityToEquity	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	803000	USD
	nwbo	Redeemable Security Settlement RedeemableSecuritySettlement	299000	USD
	nwbo	Share Based Compensation Aggregate Non Cash Charges For Non Cash Interest Associated With Accretion Of Our Convertible Notes Discount Net ShareBasedCompensationAggregateNonCashChargesForNonCashInterestAssociatedWithAccretionOfOurConvertibleNotesDiscountNet	68800000	USD
CY2015Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	19200000	USD
CY2015Q2	nwbo	Current Assets Less Payables CurrentAssetsLessPayables	95300000	USD
CY2015Q2	nwbo	Convertible Notes Payable Related Parties ConvertibleNotesPayableRelatedParties	4200000	USD
CY2015Q2	nwbo	Working Capital Deficit WorkingCapitalDeficit	113300000	USD
CY2015Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	92700000	USD
CY2015Q2	nwbo	Noncash Derivative Liability NoncashDerivativeLiability	95300000	USD
CY2015Q2	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	6200000	USD
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	10000	USD
CY2014Q4	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	8000	USD
CY2015Q2	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	50000	USD
CY2014Q4	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	50000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77727823	shares
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-672000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-604000	USD
	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	4.63
	nwbo	Weighted Average Exercise Pricewarrants Exercised On Cashless Basis WeightedAverageExercisePricewarrantsExercisedOnCashlessBasis	3.94
	nwbo	Weighted Average Exercise Price Exercised For Cash WeightedAverageExercisePriceExercisedForCash	4.18
CY2014Q4	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	4.72
CY2015Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	25657000	shares
	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	2134000	shares
	nwbo	Number Of Warrants Warrants Exercised For Cash NumberOfWarrantsWarrantsExercisedForCash	1611000	shares
	nwbo	Number Of Warrants Warrants Exercised On Cashless Basis NumberOfWarrantsWarrantsExercisedOnCashlessBasis	302000	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	29385000	shares
	nwbo	Number Of Warrants Adjustment Related To Prior Issued Warrants NumberOfWarrantsAdjustmentRelatedToPriorIssuedWarrants	257000	shares
	nwbo	Weighted Average Exercise Price Adjustment Related To Prior Issued Warrants WeightedAverageExercisePriceAdjustmentRelatedToPriorIssuedWarrants	4.31
	nwbo	Number Of Warrants Adjusted Due To Price Reset NumberOfWarrantsAdjustedDueToPriceReset	62000	shares
	nwbo	Weighted Average Price Of Warrant Adjustment Due To Price Reset WeightedAveragePriceOfWarrantAdjustmentDueToPriceReset	3.35
	nwbo	Warrants Issued During Period WarrantsIssuedDuringPeriod	14323003	shares
	nwbo	Warrants Issued Weighted Average Exercise Price Per Warrant WarrantsIssuedWeightedAverageExercisePricePerWarrant	3.3
	nwbo	Warrants Issued Weighted Average Remaining Contractual Term WarrantsIssuedWeightedAverageRemainingContractualTerm	P4Y2M12D
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	41500000	USD
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	49100000	USD
	nwbo	Cash Payments CashPayments	21300000	USD
	nwbo	Cash Payments For Services CashPaymentsForServices	2700000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.93
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4400000	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	175000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	160000	USD
CY2015Q2	us-gaap	Notes Payable NotesPayable	1172000	USD
CY2014Q4	us-gaap	Notes Payable NotesPayable	1172000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27213000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29343000	shares
CY2015Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	888187	shares
CY2015Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3700000	USD
CY2015Q1	nwbo	Fair Value Of Warrants At Issuance Date FairValueOfWarrantsAtIssuanceDate	500000	USD
CY2015Q1	nwbo	Fair Value Of Common Stock Issued For Redemption Of Redeemable Securities FairValueOfCommonStockIssuedForRedemptionOfRedeemableSecurities	300000	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	80068	shares
CY2015Q1	nwbo	Stock Issued During Period Shares Cashless Exercise Of Warrants StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants	385000	shares
CY2015Q2	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	4.76
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77727823	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68957469	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68957469	shares
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-66173000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25865000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-112674000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-71906000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	254000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	62000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"> Reclassifications</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><b><font style="FONT-SIZE: 10pt">  </font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; BACKGROUND: transparent; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The Company reclassified debt issuance costs from other long-term assets to long-term debt, net on the condensed consolidated balance sheets for all periods presented pursuant to early adoption of Accounting Standards Update ("ASU") No. 2015-03 - <i>Simplifying the Presentation of Debt Issuance Costs.</i></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><i><font style="FONT-SIZE: 10pt">  </font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">In preparing financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, valuing environmental liabilities, estimating the fair value of equity instruments recorded as derivative liabilities, and estimating the useful lives of depreciable assets and whether impairment charges may apply.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	212000	USD
CY2015Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	50000	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	50000	USD
CY2015Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	7.40
CY2015Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	5405405	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	40000000	USD
CY2015Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4500000	USD
CY2015Q2	nwbo	Stock Issued During Period Exercise Of Warrants StockIssuedDuringPeriodExerciseOfWarrants	723422	shares
CY2015Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3100000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	42174000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	40159000	USD
	us-gaap	Depreciation Depreciation	15000	USD
	us-gaap	Depreciation Depreciation	6000	USD
CY2015Q2	us-gaap	Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations	135000	USD
	us-gaap	Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations	351000	USD
CY2015Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	563000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	563000	USD
CY2015Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1039000	USD
	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1360000	USD
CY2015Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	107000	USD
CY2015Q2	nwbo	Stock Issued During Period Shares Extinguishment Of Warrant Liabilities StockIssuedDuringPeriodSharesExtinguishmentOfWarrantLiabilities	9200	shares
CY2015Q2	nwbo	Stock Issued During Period Value Extinguishment Of Warrant Liabilities StockIssuedDuringPeriodValueExtinguishmentOfWarrantLiabilities	60000	USD
CY2015Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	701033	shares
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51713000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21266000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	798000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5812000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-9646000	USD
	nwbo	Stock Issued During Period Value Conversion Of Accrued Interest StockIssuedDuringPeriodValueConversionOfAccruedInterest	187000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	4500000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	58000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40000000	USD
	us-gaap	Proceeds From Mortgage Deposits ProceedsFromMortgageDeposits	0	USD
	us-gaap	Proceeds From Mortgage Deposits ProceedsFromMortgageDeposits	-3414000	USD
	us-gaap	Interest Paid InterestPaid	-673000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	521000	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	51000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Warrants Exercised For Cash ReclassificationOfWarrantLiabilitiesRelatedToWarrantsExercisedForCash	58000	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Warrants Exercised For Cash ReclassificationOfWarrantLiabilitiesRelatedToWarrantsExercisedForCash	0	USD
	nwbo	Issuance Of Common Stock For Debt Conversion IssuanceOfCommonStockForDebtConversion	4500000	USD
	nwbo	Issuance Of Common Stock For Debt Conversion IssuanceOfCommonStockForDebtConversion	0	USD
	nwbo	Issuance Of Common Stock For Conversion Of Accrued Interest IssuanceOfCommonStockForConversionOfAccruedInterest	187000	USD
	nwbo	Issuance Of Common Stock For Conversion Of Accrued Interest IssuanceOfCommonStockForConversionOfAccruedInterest	0	USD
	nwbo	Stock Issued During Period Value Proceeds From Warrants Exercises StockIssuedDuringPeriodValueProceedsFromWarrantsExercises	6792000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3087000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6792000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2059000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	nwbo	Proceeds From Issuance Of Common Stock Over Allotment Rights ProceedsFromIssuanceOfCommonStockOverAllotmentRights	0	USD
	nwbo	Proceeds From Issuance Of Common Stock Over Allotment Rights ProceedsFromIssuanceOfCommonStockOverAllotmentRights	15000000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1105000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	15784000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3389000	USD
	nwbo	Cash Payments CashPayments	12400000	USD
CY2015Q2	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	234000	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	234000	USD

Files In Submission

Name	View Source	Status
0001144204-15-047830-index-headers.html	Edgar Link	pending
0001144204-15-047830-index.html	Edgar Link	pending
0001144204-15-047830.txt	Edgar Link	pending
0001144204-15-047830-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nwbo-20150630.xml	Edgar Link	completed
nwbo-20150630.xsd	Edgar Link	pending
nwbo-20150630_cal.xml	Edgar Link	unprocessable
nwbo-20150630_def.xml	Edgar Link	unprocessable
nwbo-20150630_lab.xml	Edgar Link	unprocessable
nwbo-20150630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v416949_10q.htm	Edgar Link	pending
v416949_ex31-1.htm	Edgar Link	pending
v416949_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2015 Q2 Form 10-Q Financial Statement

#000114420415047830 Filed on August 10, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2015 Q2 Form 10-Q Financial Statement

#000114420415047830 Filed on August 10, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo